Skip to content

Clinical trials

Completed Phase 2 Eye Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Eye Diseases Phase: Phase 2 Status: Completed Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20073
20081
20092
20112
20121
20131
20142
20161
20191
20202
20211
20225
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Neurotech Pharmaceuticals3
Amakem, NV2
LENZ Therapeutics, Inc2
Nanoscope Therapeutics Inc.2
Adverum Biotechnologies, Inc.1
Alcon Research1
Alkahest, Inc.1
Amgen1
Glaukos Corporation1
Lassen Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eye Diseases28
Retinal Diseases11
Retinal Degeneration6
Macular Degeneration4
Retinitis Pigmentosa4
Edema3
Eye Diseases, Hereditary3
Glaucoma3
Macular Edema3
Ocular Hypertension3

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.